Campbell & Co Investment Adviser’s Axonics, Inc. Common Stock AXNX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,918	Closed	-$1.16M	–	1233
2023 Q2	$1.16M	Sell	22,918 -689	-3%	-$36.7K	0.21%	114
2023 Q1	$1.29M	Buy	23,607 +2,851	+14%	+$167K	0.24%	97
2022 Q4	$1.3M	Buy	20,756 +6,597	+47%	+$438K	0.31%	49
2022 Q3	$997K	Buy	14,159 +9,240	+188%	+$637K	0.23%	132
2022 Q2	$279K	Buy	+4,919	New	+$270K	0.08%	489

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Campbell & Co Investment Adviser's AXNX Position: Q3 2023 in Review

Campbell & Co Investment Adviser sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 22,918 shares — an estimated $1.16M sold.

Campbell & Co Investment Adviser first reported a position in AXNX in Q2 2022 and held it in 5 quarters. The position peaked at $1.3M in Q4 2022. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

Campbell & Co Investment Adviser reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Campbell & Co Investment Adviser sold 22,918 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $1.16M.
Campbell & Co Investment Adviser first reported a position in Axonics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Campbell & Co Investment Adviser's Axonics, Inc. Common Stock position peaked at $1.3M in Q4 2022.
221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2023, filed 8 Nov 2023.